Aging — Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects
Citation(s)
Alcedo J, Kenyon C Regulation of C. elegans longevity by specific gustatory and olfactory neurons. Neuron. 2004 Jan 8;41(1):45-55.
Apfeld J, Kenyon C Regulation of lifespan by sensory perception in Caenorhabditis elegans. Nature. 1999 Dec 16;402(6763):804-9.
Arai T, Yusa S, Kirimura K, Usami S Cloning and sequencing of the cDNA encoding lipase I from Trichosporon fermentans WU-C12. FEMS Microbiol Lett. 1997 Jul 1;152(1):183-8. Erratum in: FEMS Microbiol Lett 1997 Sep 15;154(2):423-4.
Baylin SB, Jones PA A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011 Sep 23;11(10):726-34. doi: 10.1038/nrc3130. Review.
BLUEPRINT consortium Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nat Biotechnol. 2016 Jul;34(7):726-37. doi: 10.1038/nbt.3605. Epub 2016 Jun 27.
Burrows B, Lebowitz MD, Camilli AE, Knudson RJ Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. Am Rev Respir Dis. 1986 Jun;133(6):974-80.
Campisi J, d'Adda di Fagagna F Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40. Review.
Conboy IM, Rando TA Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle. 2005 Mar;4(3):407-10. Epub 2005 Mar 7. Review.
Conboy IM, Rando TA The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell. 2002 Sep;3(3):397-409.
Conboy MJ, Conboy IM, Rando TA Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity. Aging Cell. 2013 Jun;12(3):525-30. doi: 10.1111/acel.12065. Epub 2013 Apr 10. Review.
Eggel A, Wyss-Coray T A revival of parabiosis in biomedical research. Swiss Med Wkly. 2014 Feb 4;144:w13914. doi: 10.4414/smw.2014.13914. Review.
Fraga MF, Esteller M Epigenetics and aging: the targets and the marks. Trends Genet. 2007 Aug;23(8):413-8. Epub 2007 Jun 7. Review.
Gavrilov LA, Gavrilova NS The reliability theory of aging and longevity. J Theor Biol. 2001 Dec 21;213(4):527-45. Review.
Horvath S DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115. Erratum in: Genome Biol. 2015;16:96.
Jeong DE, Artan M, Seo K, Lee SJ Regulation of lifespan by chemosensory and thermosensory systems: findings in invertebrates and their implications in mammalian aging. Front Genet. 2012 Oct 18;3:218. doi: 10.3389/fgene.2012.00218. eCollection 2012.
Kenyon CJ The genetics of ageing. Nature. 2010 Mar 25;464(7288):504-12. doi: 10.1038/nature08980. Review. Erratum in: Nature. 2010 Sep 30;467(7315):622.
Koch CM, Wagner W Epigenetic-aging-signature to determine age in different tissues. Aging (Albany NY). 2011 Oct;3(10):1018-27.
Lei MK, Beach SR, Dogan MV, Philibert RA A pilot investigation of the impact of smoking cessation on biological age. Am J Addict. 2017 Mar;26(2):129-135. doi: 10.1111/ajad.12502. Epub 2017 Jan 20.
Levine ME, Lu AT, Bennett DA, Horvath S Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning. Aging (Albany NY). 2015 Dec;7(12):1198-211.
Perna L, Zhang Y, Mons U, Holleczek B, Saum KU, Brenner H Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort. Clin Epigenetics. 2016 Jun 3;8:64. doi: 10.1186/s13148-016-0228-z. eCollection 2016.
Rando TA Stem cells, ageing and the quest for immortality. Nature. 2006 Jun 29;441(7097):1080-6. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.